Skip to content

Speech Intelligibility in Quiet and Noise for New vs. Legacy Hearing Aids

Speech Intelligibility in Quiet and Noise for New Versus Legacy Hearing Aids

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05101083
Enrollment
34
Registered
2021-11-01
Start date
2021-10-25
Completion date
2022-01-10
Last updated
2022-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Loss, Hearing Loss, Sensorineural

Brief summary

This clinical investigation is designed to compare audiological performance (i.e., measurements of sound quality and speech understanding) between Starkey's new receiver-in-canal device and a commercially available legacy receiver-in-canal device.

Detailed description

Starkey is investigating a new hearing aid with several new audiological features. These features have been assessed for benefit, individually, but this clinical investigation will serve as a test for safety and efficacy with all hearing aid features, together. The design of this study is a single-blinded, crossover design and will be conducted at Starkey's headquarters in Eden Prairie, MN.

Interventions

DEVICENew Receiver-in-Canal Device

Successor of previous device generation

DEVICELegacy Receiver-in-Canal Device

Receiver-in-canal device available on the market

Sponsors

Starkey Laboratories, Inc
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Crossover Assignment - Each participant will experience both test conditions (counterbalanced)

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults, minimum age of 18 * Native English speakers * Ability to complete questionnaires and laboratory assessments * Symmetric, mild to moderately-severe sensorineural hearing loss * Informed consent completed with signature

Exclusion criteria

* Inability to visit the Starkey Headquarters building for testing * Central or middle ear hearing problems * Medical contraindications to wearing hearing aids * Learning disability, major cognitive handicap, or serious neurological or psychiatric disease that would prevent or restrict participation, as determined by the PI or designee

Design outcomes

Primary

MeasureTime frameDescription
Speech intelligibility (% words repeated back correctly) in quiet and noise for new vs. legacy hearing aidsFour weeksIEEE sentences will be presented to the research participants in quiet and in background noise. The percent words repeated back correctly will be scored and serve as the reported result of this outcome measure.

Secondary

MeasureTime frameDescription
First fit ratings of sound quality on subjective questionnaires for the new vs. legacy hearing aidsFour weeksThis data will be collected through lab testing following the first fit of the hearing aids. Participants will answer questionnaire items related to their impressions of sound quality. Results will be collected using a 7-point Likert scale, and ratings (1-7) will be analyzed using descriptive statistics. Statistical measures for repeated measurements will be used to understand any differences between hearing aid conditions.
Safety of the new, receiver-in-canal devices through tracking of adverse eventsFour weeksThis data will be collected through the tracking of adverse events.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026